GRDN
$34.09
Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States.
Recent News
Assessing Guardian Pharmacy Services (GRDN) Valuation As Shares Trade Slightly Below Estimated Fair Value
Guardian Pharmacy Services stock context Guardian Pharmacy Services (GRDN) has drawn investor attention after recent trading left the shares at a last close of US$32.59, with returns mixed across the month and the past 3 months. See our latest analysis for Guardian Pharmacy Services. While the latest 1 day share price return of a 2.04% decline and 30 day share price return of a 2.60% decline point to some cooling, the 90 day share price return of 7.06% and 1 year total shareholder return of...
Guardian Pharmacy Services Inc (GRDN) Q4 2025 Earnings Call Highlights: Strong Revenue Growth ...
Guardian Pharmacy Services Inc (GRDN) reports robust financial performance with significant revenue and EBITDA growth, while navigating industry challenges and expanding its operational footprint.
Guardian Pharmacy Services, Inc. Q4 2025 Earnings Call Summary
Moby summary of Guardian Pharmacy Services, Inc.'s Q4 2025 earnings call
Guardian Pharmacy (GRDN) Earnings Transcript
My name is Ashley Stockton, Vice President, Investor Relations for Guardian Pharmacy Services, Inc. I am joined on today's call by Fred Burke, President and Chief Executive Officer, and David Morris, Chief Financial Officer. After the close today, Guardian Pharmacy Services, Inc. posted its financial results for the quarter ended 12/31/2025.
Guardian Pharmacy Services Q4 Earnings Call Highlights
Guardian Pharmacy Services (NYSE:GRDN) reported fourth-quarter and full-year 2025 results that management said exceeded expectations, driven by continued resident growth, higher script volumes, improved vaccine economics, and contributions from acquisitions and greenfield startups. Executives also u